Rallybio Corporation (RLYB)
undefined
undefined%
At close: undefined
1.12
1.35%
After-hours Dec 13, 2024, 06:32 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -74.56M -66.65M -47.01M -26.45M -17.56M
Depreciation & Amortization 150.00K 167.00K 109.00K 62.00K 26.00K
Stock-Based Compensation 10.92M 9.50M 3.65M 704.00K 194.00K
Other Working Capital 4.38M -1.42M -2.80M 1.40M 1.34M
Other Non-Cash Items -1.05M 640.00K 1.50M 1.52M 144.00K
Deferred Income Tax - - - - 103.00K
Change in Working Capital 4.28M -936.00K -3.78M 2.12M 2.07M
Operating Cash Flow -60.27M -57.28M -45.53M -22.04M -15.03M
Capital Expenditures -12.00K -54.00K -333.00K -137.00K -188.00K
Acquisitions -2.25M -300.00K -2.00M -1.94M -
Purchase of Investments -110.66M -201.32M -2.00M -1.94M -
Sales Maturities Of Investments 138.33M 89.50M 2.00M 1.94M -
Other Investing Acitivies 2.25M -112.12K -2.00K -1.94K -
Investing Cash Flow 27.66M -112.17M -2.33M -2.07M -188.00K
Debt Repayment - - - - -
Common Stock Repurchased 282.00K - - - -
Dividend Paid - - - - -
Other Financial Acitivies 143.00K -455.00K -3.23M -319.00K -33.00K
Financial Cash Flow 143.00K 51.08M 82.97M 144.89M 31.57M
Net Cash Flow -32.46M -118.38M 35.10M 120.78M 16.35M
Free Cash Flow -60.28M -57.34M -45.87M -22.18M -15.21M